Vasoactive intestinal peptide re-balances TREM-1/TREM-2 ratio in acute lung injury

Regulatory Peptides

Volumn 167, Issue 1, 2011, Pages 56-64

  Sun, Guo Ying ^a   Guan, Cha Xiang ^a   Zhou, Yong ^a   Liu, Yong Ping ^b   Li, Shu Fen ^a   Zhou, Hui Fang ^a   Tang, Chun Yan ^a   Fang, Xiang ^c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN UNIVERSITY OF CHINESE MEDICINE   (China)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Acute lung injury; Macrophage; TREM 1; TREM 2; Vasoactive intestinal peptide

Indexed keywords

LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; MESSENGER RNA; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 1; TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL ACTIVITY; BRONCHUS MUCOSA; CARCINOMA CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; FIBROBLAST; GENE EXPRESSION REGULATION; GENE REPRESSION; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; LUNG ALVEOLUS MACROPHAGE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION;

ACUTE LUNG INJURY; ADENOCARCINOMA; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; LUNG; LUNG NEOPLASMS; MALE; MEMBRANE GLYCOPROTEINS; MICE; MYELOID CELLS; NEOPLASMS; NEUROPROTECTIVE AGENTS; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER; VASOACTIVE INTESTINAL PEPTIDE;

ANIMALIA; MUS;

EID: 79951681737     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.11.008     Document Type: Article

References (31)

1. Olopade C.O., Yu J., Abubaker J., Mensah E., Paul S. Catalytic hydrolysis of VIP in pregnant women with asthma. J Asthma 2006, 43(6):429-432.
2. Maruno K., Absood A., Said S.I. VIP inhibits basal and histamine-stimulated proliferation of human airway smooth muscle cells. Am J Physiol 1995, 268:L1047-L1051.
3. Rudholm T., Wallin B., Theodorsson E., Näslund E., Hellström P.M. Release of regulatory gut peptides somatostatin, neurotensin and vasoactive intestinal peptide by acid and hyperosmolal solutions in the intestine in conscious rats. Regul Pept 2009, 152(1-3):8-12.
4. Gürkan A., Emingil G., Nizam N., Doǧanavşargil B., Sezak M., Kütükçüler N., et al. Therapeutic efficacy of vasoactive intestinal peptide in escherichia coli lipopolysaccharide-induced experimental periodontitis in rats. J Periodontol 2009, 80(10):1655-1664.
5. Arranz A., Gutiérrez-Cañas I., Carrión M., Juarranz Y., Pablos J.L., Martínez C., et al. VIP reverses the expression profiling of TLR4-stimulated signaling pathway in rheumatoid arthritis synovial fibroblasts. Mol Immunol 2008, 45(11):3065-3073.
6. Alves E.P., Alves A.M., Pereira R.V., de Miranda Neto M.H., Zanoni J.N. Immunohistochemical study of vasoactive intestinal peptide (VIP) enteric neurons in diabetic rats supplemented with L-glutamine. Nutr Neurosci 2010, 13(1):43-51.
7. Zhou M.T., Chen C.S., Chen B.C., Zhang Q.Y., Andersson R. Acute lung injury and ARDS in acute pancreatitis: mechanisms and potential intervention. World J Gastroenterol 2010, 16(17):2094-2099.
8. Sharif O., Knapp S. From expression to signaling: roles of TREM-1 and TREM-2 in innate immunity and bacterial infection. Immunobiology 2008, 213(9-10):701-713.
9. Zanzinger K., Schellack C., Nausch N., Cerwenka A. Regulation of triggering receptor expressed on myeloid cells 1 expression on mouse inflammatory monocytes. Immunology 2009, 128(2):185-195.
10. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006, 177(4):2051-2055.
11. Tsushima K., King L.S., Aggarwal N.R., De Gorordo A., D'Alessio F.R., Kubo K. Acute lung injury review. Intern Med 2009, 48(9):621-630.
12. Samarasinghe A.E., Hoselton S.A., Schuh J.M. Spatio-temporal localization of vasoactive intestinal peptide and neutral endopeptidase in allergic murine lungs. Regul Pept 2010, 164(2-3):151-157.
13. Said S.I. Vasoactive intestinal polypeptide (VIP) in asthma. Ann NY Acad Sci 1991, 629:305-318.
14. Misaka S., Aoki Y., Karaki S., Kuwahara A., Mizumoto T., Onoue S., et al. Inhalable powder formulation of a stabilized vasoactive intestinal peptide (VIP) derivative: anti-inflammatory effect in experimental asthmatic rats. Peptides 2010, 31(1):72-78.
15. Guan C.X., Zhang M., Qin X.Q., Cui Y.R., Luo Z.Q., Bai H.B., et al. Vasoactive intestinal peptide enhances wound healing and proliferation of human bronchial epithelial cells. Peptides 2006, 27(12):3107-3114.
16. Guan C.X., Cui Y.R., Sun G.Y., Yu F., Tang C.Y., Li Y.C., et al. Role of CREB in vasoactive intestinal peptide-mediated wound healing in human bronchial epithelial cells. Regul Pept 2009, 153(1-3):64-69.
17. Murakami Y., Kohsaka H. Triggering receptor expressed on myeloid cells-1 as an inflammation amplifier. Nihon Rinsho Meneki Gakkai Kaishi 2009, 32(4):242-248.
18. Turnbull I.R., Gilfillan S., Cella M., Aoshi T., Miller M., Piccio L., et al. Cutting edge: TREM-2 attenuates macrophage activation. J Immunol 2006, 177(6):3520-3524.
19. Day J., Friedman A., Schlesinger L.S. Modeling the immune rheostat of macrophages in the lung in response to infection. Proc Natl Acad Sci 2009, 106(27):11246-11251.
20. Zhai Z., Solco A., Wu L., Wurtele E.S., Kohut M.L., Murphy P.A., et al. Echinacea increases arginase activity and has anti-inflammatory properties in RAW 264.7 macrophage cells, indicative of alternative macrophage activation. J Ethnopharmacol 2009, 122(1):76-85.
21. Brown J.N., Kohler J.J., Coberley C.R., Sleasman J.W., Goodenow M.M. HIV-1 activates macrophages independent of Toll-like receptors. PLoS ONE 2008, 3(12):e3664.
22. Mario Delgado, David Pozo, Carmen Martinez, Javier Leceta, Juan Ramon Calvo, Doina Ganea, et al. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit endotoxin-induced TNF-α production by macrophages: in vitro and in vivo studies. J Immunol 1999, 162(4):2358-2367.
23. Ding W., Wagner J.A., Granstein R.D. CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappa B activation. J Invest Dermatol 2007, 127(10):2357-2367.
24. Fernández-Martínez A.B., Collado B., Bajo A.M., Sánchez-Chapado M., Prieto J.C., Carmena M.J. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kappa B in human prostate cell lines Differential time-dependent responses in cancer progression. Mol Cell Endocrinol 2007, 270(1-2):8-16.
25. Gomariz R.P., Arranz A., Juarranz Y., Gutierrez-Cañas I., Garcia-Gomez M., Leceta J., et al. Regulation of TLR expression, a new perspective for the role of VIP in immunity. Peptides 2007, 28(9):1825-1832.
26. Foster N., Lea S.R., Preshaw P.M., Taylor J.J. Pivotal advance: vasoactive intestinal peptide inhibits up-regulation of human monocyte TLR2 and TLR4 by LPS and differentiation of monocytes to macrophages. J Leukoc Biol 2007, 81(4):893-903.
27. Gomariz R.P., Gutiérrez-Cañas I., Arranz A., Carrión M., Juarranz Y., Leceta J., et al. Peptides targeting Toll-like receptor signaling pathways for novel immune therapeutics. Curr Pharm Des 2010, 16(9):1063-1080.
28. Zeng H., Ornatowska M., Joo M.S., Sadikot R.T. TREM-1 expression in macrophages is regulated at transcriptional level by NF-kappa B and PU.1. Eur J Immunol 2007, 37(8):2300-2308.
29. Park-Min K.H., Ji J.D., Antoniv T., Reid A.C., Silver R.B., Humphrey M.B., et al. IL-10 suppresses calcium-mediated costimulation of receptor activator NF-kappa B signaling during human osteoclast differentiation by inhibiting TREM-2 expression. J Immunol 2009, 183(4):2444-2455.
30. Ornatowska M., Azim A.C., Wang X., Christman J.W., Xiao L., Joo M., et al. Functional genomics of silencing TREM-1 on TLR4 signaling in macrophages. Am J Physiol Lung Cell Mol Physiol 2007, 293(6):L1377-L1384.
31. Hamerman J.A., Jarjoura J.R., Humphrey M.B., Nakamura M.C., Seaman W.E., Lanier L.L. Cutting edge: inhibition of TLR and FcR responses in macrophages by triggering receptor expressed on myeloid cells (TREM)-2 and DAP12. J Immunol 2006, 177(4):2051-2055.